(Q91123974)
Statements
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial (English)
Arnaud Scherpereel
Julien Mazieres
Laurent Greillier
Sylvie Lantuejoul
Pascal Dô
Olivier Bylicki
Isabelle Monnet
Romain Corre
Clarisse Audigier-Valette
Myriam Locatelli-Sanchez
Olivier Molinier
Thierry Urban
Catherine Ligeza-Poisson
David Planchard
Elodie Amour
Franck Morin
Gérard Zalcman
French Cooperative Thoracic Intergroup